The Valley Desk

NCT07252050 · Interventional trial

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Graft Failure, Haploidentical Hematopoietic Stem Cell Transplant, Haploidentical Stem Cell Transplantation, Hematopoetic Stem Cell Transplant, Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov